Failure rates for medications can be as high as 75%. We believe it’s time to change this so that patients and providers have better outcomes.
Genetic factors account for up to 95% of the errors in medication failure rates.
That’s why Claritas PSM has partnered with RxGenomix. By integrating pharmacogenomics into the patient care process, we can improve outcomes while significantly reducing overall healthcare costs.
RxGenomix was created to help pharmacists and other healthcare providers use pharmacogenomics (PGx) to make sure the right medications are prescribed for each individual, based on their own unique genetics. This kind of precision medicine speeds the time to achieving therapeutic benefit, reduces unnecessary medication use, decreases the chance of side effects/dependency and reduces the need for more intensive care.
The need for pharmacogenomics (PGx):
• can crack the code for which medications work for a particular individual.
• Using drugs that are not genetically appropriate for a particular individual can lead to ineffective therapies and adverse drug reactions (ADRs).
• ADRs rise exponentially when 4 or more medications are taken and 29% of Americans take more than 5 medications.
• ADRs are the leading cause of hospitalization and the 4th leading cause of death in the United States.
Projected cost savings in the general population:
• Studies have shown therapies NOT guided by PGx testing incurred an additional $5188 in annual healthcare costs, compared to PGx-guided therapies.
• This represents a cost savings of approximately 15:1 when integrating PGx testing into the treatment plan.
Regarding psychiatric medications:
• 16% of U.S. adults have taken a psychiatric medication in the past year
• Approximately half of all people have a genetic mutation that renders one or more classes of anti-depressant medications less effective or entirely ineffective. This leads to trial-and-error therapy that can take months.
• With testing, genetically appropriate medications can be prescribed the first time. Without PGx testing, many patients struggle for months or years to find effective medications.
In Workers’ Compensation Cases:
• The average workers’ compensation claim costs $37,000 and results in lost work time averaging 212 calendar days. (NCCI 2015)
• Approximately 35% of the $37,000 spent is on pharmaceuticals which may or may not be genetically appropriate for the individual.
How We Put PGx to Work For You
Pharmacists are the medication experts in the healthcare spectrum. By engaging them and having them complete rigorous training in pharmacogenomics, they can provide critical guidance to physicians in the application of PGx to patient care.